The Supreme Court seemed open on April 18 to revive whistleblower lawsuits against pharmacy operators SuperValu and Safeway for allegedly submitting false Medicare and Medicaid reimbursement claims for prescription drugs they sold.
The case is considered to be important because it could have an impact on the government’s ability to crack down on health care fraud.
